Secular Trends in Use of Disease Modifying Anti-Rheumatic Drugs for the Treatment of Rheumatoid Arthritis in the United States

被引：0
|
作者：
Desai, Rishi J. [1 ]
Solomon, Daniel H. [2 ]
Liu, Jun [3 ]
Kim, Seoyoung C. [4 ]
机构：
[1] Brigham & Womens Hosp, PharmacoEpidemiol & PharmacoEcon, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Rheumatol, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Div Pharmacoepidemiol, Boston, MA 02115 USA
[4] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2015年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2725
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Use of disease modifying anti-rheumatic drugs and risk of multiple myeloma in US Veterans with rheumatoid arthritis
    Tokareva, Kate
    Peterson, Alexander C.
    Baraff, Aaron
    Chung, Sarah P.
    Barton, Jennifer
    Baker, Joshua F.
    England, Bryant R.
    Mikuls, Ted R.
    Smith, Nicholas L.
    Coffey, David G.
    Weiss, Noel S.
    Singh, Namrata
    BMC RHEUMATOLOGY, 2025, 9 (01)
  • [22] USE OF BIOLOGIC OR TARGETED SYNTHETIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS AND THE RISK OF LYMPHOMA IN RHEUMATOID ARTHRITIS
    Singh, N.
    Peterson, A.
    Baraff, A.
    Bhatti, P.
    Gopal, A.
    Smith, N.
    Barton, J.
    Curtis, J.
    Li, C.
    Weiss, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1060 - 1061
  • [23] Use of Biologic or Targeted Synthetic Disease Modifying Anti-rheumatic Drugs and the Risk of Lymphoma in Rheumatoid Arthritis
    Singh, Namrata
    Peterson, Alexander
    Baraff, Aaron
    Gopal, Ajay
    Smith, Nicholas
    Barton, Jennifer
    Curtis, Jeffrey
    Weiss, Noel
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2381 - 2382
  • [24] Use of Disease Modifying Anti-rheumatic Drugs and Risk of Multiple Myeloma in US Veterans with Rheumatoid Arthritis
    Singh, Namrata
    Peterson, Alexander
    Baraff, Aaron
    Chung, Sarah
    Coffey, David
    England, Bryant
    Reid, Pankti
    Baker, Joshua
    Barton, Jennifer
    Smith, Nicholas
    Mikuls, Ted
    Weiss, Noel
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1834 - 1835
  • [25] Treatment Patterns of Disease-Modifying Anti-Rheumatic Drugs by Serostatus Among Patients with Rheumatoid Arthritis
    Jin, Yinzhu
    Liu, Jun
    Desai, Rishi
    Kim, Seoyoung
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 3476 - 3479
  • [26] Safety, cost and effectiveness issues with disease modifying anti-rheumatic drugs in rheumatoid arthritis
    Fries, JF
    ANNALS OF THE RHEUMATIC DISEASES, 1999, 58 : 86 - 89
  • [27] ADHERENCE TO BIOLOGIC AND CONVENTIONAL DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Mishra, P.
    VALUE IN HEALTH, 2018, 21 : S198 - S198
  • [28] THE MODERATING EFFECTS OF DEPRESSION ON BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS
    Rathbun, A. M.
    Harrold, L. R.
    Reed, G. W.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 631 - 631
  • [29] Retention rates of disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis
    Agarwal, S.
    Zaman, T.
    Handa, R.
    SINGAPORE MEDICAL JOURNAL, 2009, 50 (07) : 686 - 692
  • [30] Effectiveness of sequential biologic and targeted disease modifying anti-rheumatic drugs for rheumatoid arthritis
    Zhao, Sizheng Steven
    Kearlsey-Fleet, Lianne
    Bosworth, Ailsa
    Watson, Kath
    Hyrich, Kimme L.
    RHEUMATOLOGY, 2022, 61 (12) : 4678 - 4686
12345